NOT-AI-04-048: ADDENDUM TO RFA-AI-04-001

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®

ADDENDUM TO RFA-AI-04-001

RELEASE DATE: July 27, 2004

NOTICE:  NOT-AI-04-048

EXPIRATION DATE: June 9, 2005, unless reissued

National Institute of Allergy and Infectious Diseases (NIAID) 
(http://www.niaid.nih.gov)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 
(http://www.niams.nih.gov/)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 
(http://www.niddk.nih.gov/) 
National Institute of Neurological Disorders and Stroke (NINDS) 
(http://www.ninds.nih.gov/)

LETTER OF INTENT RECEIPT DATES: One month prior to application receipt date.

APPLICATION RECEIPT DATES: Applications will be accepted MONTHLY on the 9th 
of each month. The last receipt date will be June 9, 2005.

National Institute of Allergy and Infectious Diseases (NIAID) is amending 
RFA-AI-04-001  Hyperaccelerated Award/Mechanisms In Immunomodulation Trials  
(http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-04-001.html) to change 
the following: 

1) amend the participating institutes to include those listed above;
2) provide NIAMS program staff contact information under  Where to Send 
Inquiries,  below; and
2) revise funds available and number of anticipated awards for FY2005.

The participating Institutes intend to commit approximately $1,500,000 in FY 
2005 to fund 4 to 5 new grants for immune mechanistic, ancillary studies of 
immunomodulatory interventions for immune system mediated diseases clinical 
trials and of vaccine clinical trials for non-HIV/AIDS infectious diseases. 
NIAID does not have specified funds committed in FY 2005 as were available in 
FY 2004 for immune mechanistic ancillary studies of vaccine clinical trials 
for the prevention and treatment NIAID Category A, B and C agents of 
bioterrorism and non-HIV/AIDS emerging/re-emerging infectious diseases; 
however, these applications are responsive to this RFA. 

WHERE TO SEND INQUIRIES

We encourage inquiries concerning this RFA and welcome the opportunity to 
answer questions from potential applicants. Inquiries may fall into three 
areas: scientific/research, peer review, and financial or grants management 
issues:

o Direct questions about scientific/research issues to:

Annette Rothermel, Ph.D.
Division of Allergy, Immunology and Transplantation
National Institute of Allergy and Infectious Diseases
Room 3020, MSC-6601
6610 Rockledge Drive
Bethesda, MD 20892-6601
Telephone: (301) 496-7104
FAX: (301) 480-1450
Email: [email protected]

Susana A. Serrate-Sztein, M.D.
Rheumatic Diseases Program
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Room 5AS-25E, MSC-6500
45 Center Drive
Bethesda, MD 20892-6500
Telephone: 301-594-5032
FAX: 301-480-4543
Email: [email protected]

Beena Akolkar, Ph.D.
Division of Diabetes, Endocrinology, and Metabolic Diseases
National Institute of Diabetes and Digestive and Kidney Diseases
Room 681
6707 Democracy Boulevard
Bethesda, MD 20892
Telephone: 301-594-8812
FAX:   301-480-3503
Email: [email protected]

Ursula Utz, Ph.D.
National Institute of Neurological Disorders and Stroke
Room 234, MSC-2134
6001 Executive Boulevard
Bethesda, MD 20892-2134
Telephone: 301-496-1431
FAX:  301-480-2424
Email: [email protected]

o Direct questions about peer review issues to:

Samuel C. Edwards, Ph.D.
Immunology Initial Review Group
Center for Scientific Review
Room 4200, MSC-7812
6701 Rockledge Drive
Bethesda, MD  20892-7812
(overnight carrier - FEDEX, UPS, Airborne, etc.)  20817
Telephone: 301-435-1152
FAX:   301-480-4042
Email: [email protected]

o Direct questions about financial or grants management matters to:

Ann White-Devine
Division of Extramural Activities  
National Institute of Allergy and Infectious Diseases  
Room 2118, MSC-7614
6700-B Rockledge Drive
Bethesda, MD 20892-7614  
Phone: 301-402-5601
FAX:   301-480-3780
e-mail:  [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices